Therapy of pediatric ALL relapsing after allogeneic transplant: how to make progress with limited patient numbers?
Sign Up to like & getrecommendations! Published in 2017 at "Bone Marrow Transplantation"
DOI: 10.1038/bmt.2016.276
Abstract: Therapy of pediatric ALL relapsing after allogeneic transplant: how to make progress with limited patient numbers? read more here.
Keywords: allogeneic transplant; pediatric relapsing; therapy pediatric; make progress ... See more keywords
Survivorship care for allogeneic transplant patients in the UK NHS: changes centre practice, impact of health service policy and JACIE accreditation over 5 years
Sign Up to like & getrecommendations! Published in 2020 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-020-01067-y
Abstract: Care of long-term survivors of allogeneic transplant is known to be variable despite international guidelines and accreditation standards. In 2014 a survey of UK NHS-based adult transplant centres identified significant barriers to delivery of long-term… read more here.
Keywords: term; health service; long term; allogeneic transplant ... See more keywords
Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative
Sign Up to like & getrecommendations! Published in 2020 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-020-0870-0
Abstract: Chloe Anthias ● Jane Apperley ● Adrian Bloor ● Jennifer Byrne 4 ● Matthew Collin 5 ● Charles Crawley ● Charles Craddock ● Damian Finnegan ● Maria Gilleece 9 ● John Gribben 10 ● Ann… read more here.
Keywords: diversity allogeneic; reducing diversity; allogeneic transplant; transplant protocols ... See more keywords
IMPACT OF PRE TRANSPLANT SALVAGE THERAPIES ON OUTCOME OF HODGKIN LYMPHOMA PATIENTS PERFORMING ALLOGENEIC TRANSPLANT.
Sign Up to like & getrecommendations! Published in 2022 at "Chemotherapy"
DOI: 10.1159/000525819
Abstract: BACKGROUND Allogeneic transplant is an effective salvage therapy in patients with Hodgkin lymphoma (HL) relapsed or refractory to previous treatments. In recent years, immunotherapies (conjugated antibody and checkpoint inhibitors) showed interesting results and were used… read more here.
Keywords: salvage; hodgkin lymphoma; therapies outcome; allo sct ... See more keywords
Allogeneic transplant for FLT3-ITD mutated AML: a focus on FLT3 inhibitors before, during, and after transplant
Sign Up to like & getrecommendations! Published in 2019 at "Therapeutic Advances in Hematology"
DOI: 10.1177/2040620719882666
Abstract: FMS-like tyrosine kinase 3 (FLT3) mutations are one of the most frequently encountered genetic alterations in acute myeloid leukemia (AML), and are generally associated with unfavorable outcomes. Several tools are currently available to provide an… read more here.
Keywords: transplant flt3; allogeneic transplant; flt3; mutated aml ... See more keywords
Blinatumomab and Venetoclax for Minimal Residual Disease Relapse in Acute Lymphoblastic Leukemia
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-127296
Abstract: Introduction: The 5-year relative survival in patients aged 15-24 years old is around 57% (Blood 2019; 134: 407-410), with a median survival after relapse of 10 months. No uniform consensus about rescue treatment is available,… read more here.
Keywords: combination; treatment; allogeneic transplant; relapse ... See more keywords